Work

Supplementary Data from Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figures and Figure Legends

DOI: 10.1158/1078-0432.22469031

Authors: Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, Supinya Iamsawat, Gabriela Andrejeva, Libia A. Luevano, Melissa Wolf, Uday Baliga, Carsten Krieg, Craig C. Beeson, Meenal Mehrotra, Elizabeth G. Hill, Jeffery C. Rathmell, Xue-Zhong Yu, Andrew S. Kraft, Shikhar Mehrotra

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362140563

Cites:

Cited by:

Related to: 10